タイトルまたは説明

~Arachidonic acid supplementation in daily dosages of 1,***1,**0 mg for *0 days has been well tolerated during several clinical studies, with no significant side effects reported. All common markers of health, including kidney and liver function, serum lipids,immunity, and platelet aggregation appear to be unaffected with this level and duration of use. Furthermore, higher concentrations of ARA in muscle tissue may be correlated with improved insulin sensitivity.Arachidonic acid supplementation of the diets of healthy adults appears to offer no toxicity or significant safety risk.

While studies looking at arachidonic acid supplementation in sedentary subjects have failed to find changes in resting inflammatory markers in doses up to 1,**0 mg daily, strength-trained subjects may respond differently. One study at Baylor University reported a significant reduction in resting inflammation (via marker IL*6) in young men supplementing 1,**0 mg/day of arachidonic acid for *0 days in combination with resistance training. This suggests that rather being pro-inflammatory, supplementation of ARA while undergoing resistance training may actually improve the regulation of systemic inflammation.

A meta-analysis by Cambridge University looking for associations between heart disease risk and individual fatty acids reported a significantly reduced risk of heart disease with higher levels of EPA and DHA (Omega*3 fats), as well as the Omega*6 Arachidonic Acid. A scientific advisory from the American Heart Association has also favorably evaluated the health impact of dietary omega*6 fats, including arachidonic acid. The group does not recommend limiting this essential fatty acid. In fact, the paper recommends individuals follow a diet that consists of at least **0% of calories coming from omega*6 fats, including arachidonic acid. It suggests dietary ARA is not a risk factor for heart disease, and may play a role in maintaining optimal metabolism and reduced heart disease risk. It is, therefore, recommended to maintain sufficient intake levels of both omega*3 and omega*6 fatty acids for optimal health.

Arachidonic acid is not carcinogenic, and studies show dietary level is not associated (positively or negatively) with risk of cancers. ARA remains integral to the inflammatory and cell growth process, however, which is disturbed in many types of disease including cancer. Therefore, the safety of arachidonic acid supplementation in patients suffering from cancer, inflammatory, or other diseased states is unknown, and supplementation is not recommended.